Zhejiang Taimei Medical Technology Co (HKSE:02576) LT-Debt-to-Total-Asset : 0.00 (As of Dec. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Zhejiang Taimei Medical Technology Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Zhejiang Taimei Medical Technology Co's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.00.

Zhejiang Taimei Medical Technology Co's long-term debt to total assets ratio declined from Dec. 2021 (0.02) to Dec. 2023 (0.00). It may suggest that Zhejiang Taimei Medical Technology Co is progressively becoming less dependent on debt to grow their business.

Zhejiang Taimei Medical Technology Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Zhejiang Taimei Medical Technology Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Taimei Medical Technology Co LT-Debt-to-Total-Asset Chart

Zhejiang Taimei Medical Technology Co Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

LT-Debt-to-Total-Asset

0.02

0.01

Zhejiang Taimei Medical Technology Co Semi-Annual Data
	Dec21	Dec22	Dec23	Dec24
LT-Debt-to-Total-Asset	0.02	0.01	-	0.01

Zhejiang Taimei Medical Technology Co LT-Debt-to-Total-Asset Calculation

Zhejiang Taimei Medical Technology Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	3.042	/	1580.152
	=	0.00

Zhejiang Taimei Medical Technology Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )	/	Total Assets (Q: Dec. 2023 )
	=	3.042	/	1580.152
	=	0.00

Zhejiang Taimei Medical Technology Co (HKSE:02576) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Zhejiang Taimei Medical Technology Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Zhejiang Taimei Medical Technology Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Taimei Medical Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Zhejiang Taimei Medical Technology Co Ltd (HKSE:02576) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

36 Changsheng South Road, 3rd Floor, Building 9, Smart Industry Innovation Park, Zhejiang, Jiaxing, CHN

Website

https://www.taimei.com

Zhejiang Taimei Medical Technology Co Ltd is a digital solution provider focused on the pharmaceutical and medical device industry in China, It designs and delivers industry-specific software and digital services that facilitate the research and development (R&D) as well as the commercialization of pharmaceuticals and medical devices. The software It offers is cloud-based, allowing users to access it from various devices at any time over the internet, without the need for software installation and maintenance on their devices. These cloud-based software covers critical use cases in R&D and commercialization of innovative drugs and medical devices.

Executives

Zuo Lingye	2201 Interest of corporation controlled by you
Shang Hai Jing Wei Gu Quan Tou Zi Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Hang Zhou Jing Wei Yuan Chuang Tou Zi Guan Li He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Jing Wei Chuang Teng Hang Zhou Chuang Ye Tou Zi He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Shen Zhen Shi Teng Xun Rui Tou Qi Ye Guan Li You Xian Gong Si
Teng Xun Ke Ji Shen Zhen You Xian Gong Si
Chen Yihai	2202 Interest of your spouse
Shang Hai Chen Xi Chuang Ye Tou Zi Zhong Xin You Xian He Huo	2101 Beneficial owner
Shang Hai Yuan Pan Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Xue Qiong	2201 Interest of corporation controlled by you
Ma Huateng
Lin Zhi Teng Xun Tou Zi Guan Li You Xian Gong Si
Shen Zhen Shi Teng Xun Chan Ye Tou Zi Ji Jin You Xian Gong Si
Oriental Power Holdings Limited
Shen Zhen Shi Teng Xun Rui Jian Tou Zi You Xian Gong Si

Zhejiang Taimei Medical Technology Co Headlines

No Headlines